153 related articles for article (PubMed ID: 25266800)
1. Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.
Zhao M; Xu H; Liang F; He J; Zhang J
Tumour Biol; 2015 Jan; 36(1):429-36. PubMed ID: 25266800
[TBL] [Abstract][Full Text] [Related]
2. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin regulates human glioma cell invasiveness and tumor growth in mice.
Jan HJ; Lee CC; Shih YL; Hueng DY; Ma HI; Lai JH; Wei HW; Lee HM
Neuro Oncol; 2010 Jan; 12(1):58-70. PubMed ID: 20150368
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.
Yan W; Qian C; Zhao P; Zhang J; Shi L; Qian J; Liu N; Fu Z; Kang C; Pu P; You Y
Neuro Oncol; 2010 Aug; 12(8):765-75. PubMed ID: 20511184
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
6. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.
Zhao M; Liang F; Zhang B; Yan W; Zhang J
Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583
[TBL] [Abstract][Full Text] [Related]
7. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.
Wang X; Li X; Xu F; Zhang Y; Liu H; Tao Y
Mol Neurobiol; 2016 May; 53(4):2726-32. PubMed ID: 26351078
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma.
Matusan-Ilijas K; Behrem S; Jonjic N; Zarkovic K; Lucin K
Pathol Oncol Res; 2008 Sep; 14(3):293-8. PubMed ID: 18493866
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 and the survival in glioma: a meta-analysis.
Wu G; Song X; Liu J; Li S; Gao W; Qiu M; Yang C; Ma Y; Chen Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232385
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
Yamaguchi Y; Shao Z; Sharif S; Du XY; Myles T; Merchant M; Harsh G; Glantz M; Recht L; Morser J; Leung LL
J Biol Chem; 2013 Feb; 288(5):3097-111. PubMed ID: 23204518
[TBL] [Abstract][Full Text] [Related]
11. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
[TBL] [Abstract][Full Text] [Related]
12. Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal.
Selkirk SM; Morrow J; Barone TA; Hoffer A; Lock J; DeChant A; Mangla S; Plunkett RJ; Miller RH
J Neurooncol; 2008 Feb; 86(3):285-96. PubMed ID: 17928956
[TBL] [Abstract][Full Text] [Related]
13. Identification of Secreted Phosphoprotein 1 (SPP1) as a Prognostic Factor in Lower-Grade Gliomas.
Chen J; Hou C; Zheng Z; Lin H; Lv G; Zhou D
World Neurosurg; 2019 Oct; 130():e775-e785. PubMed ID: 31295606
[TBL] [Abstract][Full Text] [Related]
14. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.
Güttler A; Giebler M; Cuno P; Wichmann H; Keßler J; Ostheimer C; Söling A; Strauss C; Illert J; Kappler M; Vordermark D; Bache M
Radiother Oncol; 2013 Sep; 108(3):535-40. PubMed ID: 23891093
[TBL] [Abstract][Full Text] [Related]
16. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935
[TBL] [Abstract][Full Text] [Related]
18. FGF2 as a potential prognostic biomarker for proneural glioma patients.
Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
20. HDAC3 Expression Correlates with the Prognosis and Grade of Patients with Glioma: A Diversification Analysis Based on Transcriptome and Clinical Evidence.
Zhong S; Fan Y; Wu B; Wang Y; Jiang S; Ge J; Hua C; Zhao G; Chen Y; Xu H
World Neurosurg; 2018 Nov; 119():e145-e158. PubMed ID: 30053564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
